Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Ribas A, Medina T, Kummar S, Amin A, Drabick JJ, Barve M, Daniels G, Wong DL, Schmidt EV, Leung AC, Janssen R. Abstract CT139: Durability of responses to the combination of SD-101 and pembrolizumab in advanced metastatic melanoma: Results of a phase Ib, multicenter study. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-ct139] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

For:	Ribas A, Medina T, Kummar S, Amin A, Drabick JJ, Barve M, Daniels G, Wong DL, Schmidt EV, Leung AC, Janssen R. Abstract CT139: Durability of responses to the combination of SD-101 and pembrolizumab in advanced metastatic melanoma: Results of a phase Ib, multicenter study. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-ct139] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Number

Cited by Other Article(s)

Olson DJ, Luke JJ. The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development. Immunotherapy 2019;11:155-159. [PMID: 30730272 PMCID: PMC7226703 DOI: 10.2217/imt-2018-0171] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Accepted: 11/01/2018] [Indexed: 01/06/2023] Open